Mismatched unrelated and haploidentical transplant with post-transplant cyclophosphamide-based graft versus host disease prophylaxis are effective for myelofibrosis

Authors

Alla Keyzner
Noa Rippel (ORCID: https://orcid.org/0000-0002-0083-6321)
Hulya Kocyigit (ORCID: https://orcid.org/0000-0003-1862-7867)
Robert S. Hoffman (ORCID: https://orcid.org/0000-0002-0091-9573)
Erin Moshier (ORCID: https://orcid.org/0000-0002-8912-4709)
John E. Levine (ORCID: https://orcid.org/0000-0002-5611-7828)
Colin J. R. Sheppard (ORCID: https://orcid.org/0000-0002-0792-4607)
John O Mascarenhas (ORCID: https://orcid.org/0000-0002-8400-0483)
Kyle Wiatrowski

Institutions

Mount Sinai Medical Center (US)
Tisch Hospital (US)
Fargo VA Health Care System (US)
Karamanoğlu Mehmetbey University (TR)
Icahn School of Medicine at Mount Sinai (US)

Publication Details

Journal: Blood
Published: 2025-11-03
DOI: https://doi.org/10.1182/blood-2025-2530
Primary Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Mismatched unrelated and haploidentical transplant with post-transplant cyclophosphamide-based graft versus host disease prophylaxis are effective for myelofibrosis

Alla Keyzner, Noa Rippel, Hulya Kocyigit, Robert S. Hoffman et al.

Nov 3, 2025

Blood

Myeloproliferative Neoplasms: Diagnosis and Treatment

article

Mismatched unrelated and haploidentical transplant with post-transplant cyclophosphamide-based graft versus host disease prophylaxis are effective for myelofibrosis

Alla Keyzner, Noa Rippel, Hulya Kocyigit, Robert S. Hoffman, Erin Moshier, John E. Levine, Colin J. R. Sheppard, John O Mascarenhas, Kyle Wiatrowski

November 3, 2025article en

Abstract

No abstract available for this paper.

BloodVol. 146(Supplement 1)

Mount Sinai Medical Center (US), Tisch Hospital (US), Fargo VA Health Care System (US), Karamanoğlu Mehmetbey University (TR), Icahn School of Medicine at Mount Sinai (US)

Openalex Percentile: Top 44%

Myeloproliferative Neoplasms: Diagnosis and Treatment

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.